440
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis

, &
Pages 1637-1645 | Accepted 09 Nov 2012, Published online: 25 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Miriam Alvarez-Payero, Candelas Valeiras-Muñoz, Susana Lion-Vázquez, Guadalupe Piñeiro-Corrales, Delicias Muñoz-García & Luciana Midaglia. (2017) Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. International Journal of Neuroscience 127:10, pages 915-922.
Read now

Articles from other publishers (4)

Peter Müller, Danielle S. Takacs, Ulrike B. S. Hedrich, Rohini Coorg, Laura Masters, Kevin E. Glinton, Hongzheng Dai, Jon A. Cokley, James J. Riviello, Holger Lerche & Edward C. Cooper. (2023) KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine . Annals of Clinical and Translational Neurology 10:4, pages 656-663.
Crossref
Kawita M. S. Kanhai, Jenny A. Nij Bijvank, Yorick L. Wagenaar, Erica S. Klaassen, KyoungSoo Lim, Sandrin C. Bergheanu, Axel Petzold, Ajay Verma, Jacob Hesterman, Mike P. Wattjes, Bernard M. J. Uitdehaag, Laurentius J. van Rijn & Geert Jan Groeneveld. (2019) Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial. CNS Neuroscience & Therapeutics 25:6, pages 697-703.
Crossref
Esther S. Kim. (2017) Fampridine Prolonged Release: A Review in Multiple Sclerosis Patients with Walking Disability. Drugs 77:14, pages 1593-1602.
Crossref
Anil Sindhurakar, Asht M. Mishra, Disha Gupta, Jennifer F. Iaci, Tom J. Parry & Jason B. Carmel. (2017) Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract Injury. Neurorehabilitation and Neural Repair 31:4, pages 387-396.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.